Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results

PURPOSE: To evaluate vaginal toxicity (primary endpoint) and local control (secondary endpoint) in patients with endometrial cancer who underwent primary surgery and adjuvant high-dose-rate (HDR) endovaginal brachytherapy (BT). MATERIAL AND METHODS: In September 2017, the authors conducted a compreh...

Descripción completa

Detalles Bibliográficos
Autores principales: Delishaj, Durim, Barcellini, Amelia, D’Amico, Romerai, Ursino, Stefano, Pasqualetti, Francesco, Fumagalli, Ilaria Costanza, Soatti, Carlo Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335557/
https://www.ncbi.nlm.nih.gov/pubmed/30662479
http://dx.doi.org/10.5114/jcb.2018.79713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335557/
https://www.ncbi.nlm.nih.gov/pubmed/30662479
http://dx.doi.org/10.5114/jcb.2018.79713

Ejemplares similares